Vanguard Total Stock Market ETF (VTI)
270.24
-0.79 (-0.29%)
NYSE · Last Trade: Apr 29th, 9:46 AM EDT
Detailed Quote
Previous Close | 271.03 |
---|---|
Open | 270.13 |
Day's Range | 270.06 - 270.43 |
52 Week Range | 236.42 - 303.39 |
Volume | 74,530 |
Market Cap | 4.39B |
Dividend & Yield | 3.940 (1.46%) |
1 Month Average Volume | 6,490,281 |
Chart
News & Press Releases
The company reported a 2.3% year-over-year rise in its first-quarter revenue to $44.02 billion, exceeding an analyst estimate of $43.21 billion.
Via Stocktwits · April 29, 2025
UPS is aiming to reduce its workforce by approximately 20,000 positions this year and close 73 leased and owned buildings by year-end.
Via Stocktwits · April 29, 2025
Argus said rising avocado, chicken, and pepper prices, growing competition among restaurants, and higher wage and store location costs were headwinds for the taco and burrito chain.
Via Stocktwits · April 29, 2025
Galloway Capital, which owns a 2.87% stake, says WeightWatchers should avoid bankruptcy.
Via Stocktwits · April 29, 2025
The stock could build additional momentum going into the company's first-quarter report, which is due after the market closes on May 5.
Via Stocktwits · April 29, 2025
Domino's has been selling on Uber Eats, but the exclusivity of that partnership will end in May. Domino's has indicated it will work with multiple food delivery players.
Via Stocktwits · April 29, 2025
HG Vora, which holds a less than 5% stake in Penn, said the company's action was "self-serving" and that it would continue pushing for board representation.
Via Stocktwits · April 28, 2025
The company, which operates brands such as Bed Bath & Beyond, Overstock, and Zulily, has recently made operational and management changes.
Via Stocktwits · April 28, 2025
Following the closure of the deal, Protect AI's CEO, founders, and employees are expected to join Palo Alto Networks.
Via Stocktwits · April 28, 2025
HSBC noted that while the market has assumed a significant market share for Eli Lilly, these expectations may be revised in light of potential economic sensitivity to the adoption curve for weight loss drugs.
Via Stocktwits · April 28, 2025
In a turbulent year for financial markets, US equities and real estate investment trusts are still bearing the brunt of the selling so far in 2025, based on a set of ETFs.
Via Talk Markets · April 28, 2025
The $150 billion investment will include more than $30 billion in research and development to advance and continue IBM's American manufacturing of mainframe and quantum computers.
Via Stocktwits · April 28, 2025
For the full year, Revvity raised its revenue guidance to a range of $2.83 billion to $2.87 billion to reflect recent changes in foreign currency exchange rates.
Via Stocktwits · April 28, 2025
Domino’s reported a 0.5% drop in same-store sales in the U.S. while international same-store sales rose by about 3.7%.
Via Stocktwits · April 28, 2025
Bernstein stated that after high Federal Aviation Administration (FAA) scrutiny, Boeing Commercial Airplanes "should be on a much firmer path than in 2023.”
Via Stocktwits · April 28, 2025
According to the Finchat-compiled consensus, Snap is expected to report adjusted earnings per share of $0.04 and revenue of $1.35 billion.
Via Stocktwits · April 28, 2025
The negotiations have been dragging on for a year, and the latest development could delay CEO Brian Niccol's business turnaround efforts.
Via Stocktwits · April 28, 2025
The Finchat-compiled consensus estimates call for a first-quarter loss per share of $0.39 and bookings of $1.15 billion.
Via Stocktwits · April 28, 2025
DoorDash is doing due diligence and has to submit a formal bid by May 23.
Via Stocktwits · April 28, 2025
Analyst Craig Moffett said Apple's supply chain will still be anchored in China, given that most iPhone components are still made in that country.
Via Stocktwits · April 28, 2025
Huawei's new chip is reportedly more powerful than Nvidia's H100 AI accelerator, which was released in 2022 and is built on the Hopper architecture.
Via Stocktwits · April 28, 2025
Via The Motley Fool · April 26, 2025
The company’s lead candidate, ivonescimab, aimed at treating certain cancers, was discovered by Akeso and is currently in multiple late-stage clinical trials.
Via Stocktwits · April 25, 2025
The company now expects the health benefits ratio for the full year to be in the range of 88.9% to 89.5%, up from its previous guidance of 88.4% to 89%.
Via Stocktwits · April 25, 2025